News
4d
News-Medical.Net on MSNOchsner Health shares roadmap for pharmacogenomics integration into clinical practiceIn a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the ...
5d
News-Medical.Net on MSNCannabis retailers found to be more concentrated in disadvantaged neighborhoodsA novel study reveals a significantly higher concentration of recreational (nonmedical) cannabis retailers in ...
Artificial intelligence startup OpenEvidence inked a multi-year content agreement with the JAMA Network to use content from ...
Elsevier, a global leader in medical information and data analytics, unveiled a groundbreaking evaluation framework for ...
An unsound study alleging that white doctors are responsible for worse clinical outcomes with black newborns because of “spontaneous bias” ...
Louisiana lawmakers have for the third consecutive year rejected a bill that would have added some rape cases to the narrow ...
6dOpinion
The 19th News on MSNAbortion Opponents Are Using “Junk Science” Studies to Target MifepristoneUsing flawed studies and scientific journal publications, abortion opponents are building a body of research meant to ...
The 14-story medical school of I-277, the latest towering member of the Charlotte skyline, will begin enrolling in mid-July ...
Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...
Nasus Pharma Ltd. ("Nasus Pharma" or the "Company"), a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based intranasal ("PBI") products addressing acute, community ...
CHICAGO >> Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance ...
The early switch approach in women with hormone receptor-positive, HER2-negative breast cancer resulted in a 56% reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results